Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/09/17
End: 04/30/27
Due: 04/30/28
Phase: N/A
Priority: Normal
Start: 02/01/21
End: 12/31/25
Due: 12/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) | NCT02977780 | Patrick Wen, MD | user2@example.com | None | 2017-02-09 | 2027-04-30 | 2028-04-30 | - | - | 2025-07-14 |
| Surgical Nivolumab And Ipilimumab For Recurrent GBM | NCT04606316 | Patrick Wen, MD | user2@example.com | None | 2021-02-01 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |